THERAPEUTIC AGENT FOR CANCER WHICH COMPRISES COMBINATION OF IL-18 AND MOLECULE-TARGETING ANTIBODY

• 收藏
• 分享

专利权人:

Hyogo College Of Medicine

发明人:

OKAMURA, Haruki,YAMANISHI, Kyosuke,LI, Wen

申请号：

EP15830617

公开号：

EP3178484A4

申请日:

2015.08.07

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

A cancer therapeutic agent according to an embodiment of the present invention contains, as active ingredients, IL-18 and one or more antibodies selected from the group consisting of an anti-PD-L1 antibody, an anti-PD-1 antibody, an anti-PD-L2 antibody, an anti-CTLA-4 antibody, an anti-CD25 antibody, an anti-CD33 antibody, and an anti-CD52 antibody.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/